GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Runben Biotechnology Co Ltd (SHSE:603193) » Definitions » Beneish M-Score

Runben Biotechnology Co (SHSE:603193) Beneish M-Score : -1.91 (As of Apr. 16, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Runben Biotechnology Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -1.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Runben Biotechnology Co's Beneish M-Score or its related term are showing as below:

SHSE:603193' s Beneish M-Score Range Over the Past 10 Years
Min: -1.91   Med: -1.81   Max: 0.79
Current: -1.91

During the past 5 years, the highest Beneish M-Score of Runben Biotechnology Co was 0.79. The lowest was -1.91. And the median was -1.81.


Runben Biotechnology Co Beneish M-Score Historical Data

The historical data trend for Runben Biotechnology Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Runben Biotechnology Co Beneish M-Score Chart

Runben Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - - -1.81

Runben Biotechnology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.81 - 0.79 -1.91

Competitive Comparison of Runben Biotechnology Co's Beneish M-Score

For the Household & Personal Products subindustry, Runben Biotechnology Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Runben Biotechnology Co's Beneish M-Score Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Runben Biotechnology Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Runben Biotechnology Co's Beneish M-Score falls into.


;
;

Runben Biotechnology Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Runben Biotechnology Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2589+0.528 * 0.9608+0.404 * 0.9859+0.892 * 1.2489+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0684+4.679 * 0.028913-0.327 * 0.9679
=-1.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ¥19 Mil.
Revenue was 293.488 + 577.343 + 166.683 + 209.429 = ¥1,247 Mil.
Gross Profit was 168.964 + 343.433 + 92.834 + 119.908 = ¥725 Mil.
Total Current Assets was ¥1,858 Mil.
Total Assets was ¥2,218 Mil.
Property, Plant and Equipment(Net PPE) was ¥263 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥311 Mil.
Total Current Liabilities was ¥175 Mil.
Long-Term Debt & Capital Lease Obligation was ¥2 Mil.
Net Income was 80.857 + 144.555 + 35.472 + 45.293 = ¥306 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 38.762 + 169.182 + -28.319 + 62.411 = ¥242 Mil.
Total Receivables was ¥12 Mil.
Revenue was 244.377 + 427.648 + 151.501 + 174.931 = ¥998 Mil.
Gross Profit was 140.411 + 241.656 + 80.055 + 95.762 = ¥558 Mil.
Total Current Assets was ¥678 Mil.
Total Assets was ¥987 Mil.
Property, Plant and Equipment(Net PPE) was ¥265 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥233 Mil.
Total Current Liabilities was ¥79 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(18.979 / 1246.943) / (12.071 / 998.457)
=0.01522 / 0.01209
=1.2589

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(557.884 / 998.457) / (725.139 / 1246.943)
=0.558746 / 0.581533
=0.9608

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1857.747 + 262.896) / 2218.432) / (1 - (677.882 + 264.692) / 986.688)
=0.04408 / 0.044709
=0.9859

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1246.943 / 998.457
=1.2489

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 264.692)) / (0 / (0 + 262.896))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(310.725 / 1246.943) / (232.866 / 998.457)
=0.249189 / 0.233226
=1.0684

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.763 + 175.204) / 2218.432) / ((2.508 + 78.813) / 986.688)
=0.079771 / 0.082418
=0.9679

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(306.177 - 0 - 242.036) / 2218.432
=0.028913

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Runben Biotechnology Co has a M-score of -1.91 suggests that the company is unlikely to be a manipulator.


Runben Biotechnology Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Runben Biotechnology Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Runben Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangdong, Guangzhou, CHN, 510627
Runben Biotechnology Co Ltd is engaged in research & development, production and sales of mosquito repellent and personal care products.

Runben Biotechnology Co Headlines

No Headlines